Advertisement
Advertisement
Wuxi AppTec
TOPIC
 / company

Wuxi AppTec

Wuxi AppTec
Wuxi AppTec
Wuxi AppTec is Asia's largest provider of contract pharmaceutical research, helping drug makers shorten their discovery and development procedures. Its platform is used by more than 6,000 customers, including biotech and pharmaceutical companies, research institutions, researchers, scientists and entrepreneurs in more than 30 countries. The company was founded by Ge Li, who also chairs Wuxi Biologics.
Chairman / President
Li Ge
CEO / Managing Director
Chen Minzhang
CFO / Finance Director
Shi Ming
Industry
Biopharmaceutical
Website
wuxiapptec.com
Headquarters address
288 Fute Zhong Road Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, China
Stock Code
SEHK:603259
SSE:603259
Year founded
2000
LATEST China Science NEWS

How China’s ‘pig semen eyedrop’ may help deliver Alzheimer’s treatment

videocam
Pigs were chosen for the research because their tissue structure is similar to that of humans, and their supply is abundant. Photo: Shutterstock

‘Impossible for Chinese’: Yale scientist Zhang Kai leaves US for China

videocam
23
Zhang Kai has joined the University of Science and Technology of China in Hefei, Anhui province. Photo: Handout

How to take down a US F-35 over Iran? Chinese engineer’s tutorial goes viral

videocam
17
A US Marine Corps F-35C Lightning II lands on the flight deck of the USS Abraham Lincoln at an undisclosed location during Operation Epic Fury on March 7. Photo: US Navy/Planet Pix via ZUMA Press Wire/dpa

Is China’s commercial rocket now cheaper than Elon Musk’s SpaceX Falcon 9?

videocam
12
A Kinetica-2 Y1 carrier rocket, also known as the Lijian-2 Y1, with three satellites onboard blasts off from a launch centre in northwestern China on Monday. Photo: Xinhua

China’s far west site of a new bulwark against Mideast-induced resource woes

videocam
Construction has begun on the world’s largest coal-to-ethylene glycol project in Xinjiang’s Turpan prefecture, according to state media. Photo: CCTV
MORE China Science NEWS
Despite the headwinds, there is growing interest from multinational pharmaceutical companies in partnering with Chinese biotech firms. Photo: Getty Images
China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

China’s private sector

Lab monkey price tag climbs to US$20,000 thanks to China’s biotech boom

US-China relations

Pentagon adds Chinese firms to military list, then withdraws filing

videocam
4
Hong Kong stock market

Hong Kong stocks climb as yuan strengthens and investors broaden focus beyond US

Hang Seng Index advances as investors shift focus, boosting Asian equities, with pharmaceutical and healthcare shares leading gainers.

The yuan hit its highest level since May 2023. Photo: Bloomberg
United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

US-China relations

US lawmakers want DeepSeek, Xiaomi added to list of China military-linked firms

Republicans want to add 19 more entities to the document that already includes tech giant Tencent Holdings and major ‍battery maker CATL.

videocam
17
Advertisement
Advertisement
Advertisement
Science

Why US lawmakers killed a proposal targeting science efforts with China

US researchers and industry experts warn that even the revised version may have unintended consequences.

videocam
11
A US defence bill, now awaiting President Donald Trump’s signature, includes new restrictions aimed at the medical industry and supply chains, blocking federal funds from going to biotechnology companies linked to so-called adversaries. Photo: Reuters
Hong Kong stock market

Hong Kong stocks end higher as China stimulus hopes spark property rally

Market sentiment buoyed by China homebuyer loan support talk and Vanke debt progress.

Hong Kong stock market

Hong Kong stocks extend losses amid rate-cut caution, muted China policy outlook

Global banks cite lack of urgency in policy signals; Wall Street retreat adds pressure on sentiment.

Hong Kong stock market

Hong Kong stocks fall as US data delay, Fed policy uncertainty hit sentiment

The US government will release nonfarm payrolls for September on Thursday, the first data since the 43-day shutdown.

Pedestrians walk in front of an electronic sign board showing Hong Kong stock market data. Photo: AFP
Hong Kong stock market

Hong Kong stocks fall for a second day as AI bubble fears hit Wall Street

Losses mirror Wall Street after Palantir Technologies tumbled 8 per cent despite beating revenue estimates.

Hong Kong stocks fell on Wednesday amid fears of an AI bubble. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks rise as China-US trade progress boosts sentiment

Preliminary deal made in Kuala Lumpur raises hopes for stabilisation in the trade relationship between the world’s top two economies.

Hong Kong stock market

Hong Kong stocks mirror Wall Street slide as gold and silver extend retreat

Traders weigh mixed signals from Donald Trump, who acknowledges potential meeting with Xi Jinping might not happen.

Hong Kong stock market

Hong Kong stocks post longest decline in 9 months on renewed US-China tensions

Markets react to Trump’s threat to impose a 100 per cent tariff on all Chinese imports and restrict critical software exports from November.

The Hang Seng Index is headed for its steepest decline since a 13 per cent plunge on April 7. Photo: Jelly Tse
Biomedicine: Geopolitics

Trump’s tariffs on imported drugs ‘not a big concern’ for China’s pharma firms

Chinese drug makers have ‘minimal sales exposure to the US’, Jefferies analysts say.

The Trump administration’s new 100 per cent tariff on any branded or patented pharmaceutical product takes effect on October 1. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks cap weekly decline on valuation, tariff jitters

‘Gravity has reasserted itself’ and the global US$15 trillion rebound this year ‘now feels stretched’, investor says.

Hong Kong stock market

Hong Kong stocks drop after Fed fails to signal aggressive rate road map

‘The challenge for investors is a Fed that is not yet willing to endorse their discounted future path of much lower interest rates,’ analyst says.

Advertisement
Advertisement
Advertisement
Hong Kong stock market

Hong Kong stocks waver as investors await rate-cut clarity

Ample domestic and external liquidity should fuel another rally in Hong Kong this month, strategists at China Merchants Securities say.

Chair of the US Federal Reserve Jerome Powell speaks during a news conference in Washington on July 30, 2025. Photo: Getty Images
Biomedicine: Companies

Chinese biotech firm MGI’s DNA sequencers gaining in the market, BGI CEO says

MGI’s latest product, the DNBSEQ-T7+, can sequence 144 human genomes a day, or one every 10 minutes.

Hong Kong stock market

Hong Kong stocks slip from 4-year high amid fears of US sanctions on drug makers

The Trump administration has been discussing severe restrictions on medicines from China, according to The New York Times.

Banking & finance

China’s healthcare segment eyes record fundraising amid global investor surge

China biotech remains a market bright spot with strong growth, driven by out-licensing, efficiency improvements and cost control.

Investor focus was on companies that address cardiovascular, cancer and other life-threatening conditions. Photo: Shutterstock
China technology

China’s biotech industry is gaining on the US. Can tariffs hold them back?

Pharmaceutical firms in China have grown fast, but geopolitics and a long head start could keep US-based leaders at industry apex - for now.

videocam
Illustration: Lau Ka-kuen
Hong Kong stock market

Mainland Chinese and Hong Kong stocks end the week on a high note

Shanghai Composite Index rises 1.5 per cent to 3,825.76, the highest since August 17, 2015.

videocam
China economy

Editorial | As stimulus beds in, this Chinese stock rally may have legs

Encouraged by government stimulus, strong earnings and low deposit rates, investors are returning to Chinese stocks.

Banking & finance

Wuxi AppTec joins funding rush as appetite grows for China’s biotech

WuxiAppTec raised HK$7.70 billion (US$981 million) in a sale of additional shares to fund its global expansion.

Wuxi AppTec’s research center in Shanghai on June 6, 2023. Photo: Getty Images
Hong Kong stock market

Hong Kong stocks slide to 2-week low on Fed decision, China manufacturing data

China’s official manufacturing purchasing managers’ index falls to 49.3 in July from 49.7 in June.

Exchange Square in Central. Photo: EPA-EFE
Hong Kong stock market

Hong Kong stocks sustain 3-year-high level on trade optimism

A US deal with Japan and scheduled talks with China reduce concerns about damage to the global economy from trade conflicts.

US-China trade war

What are China’s ‘future industries’? And why they count in the global tech race

From humanoids to quantum computing, Beijing wants to reshape its economy – and lead the world in next-gen technologies.

videocam
4
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement